E-therapeutics Share Discussion Threads

[gnnmartin] 20/3/2019 13:33

No idea. The AGM is on 30TH April. I can't go, but would like to hear from anyone who does. I've put this away (metaphorically speaking) with my two pounds worth of premium bonds. I doubt I will win a prize from either, but ...

[jpuff] 20/3/2019 11:04

Gosh, what's the share price collapse all about? Looks like I have yet another disaster on my hands. Anyone else out there with a view?

[dynoport] 10/12/2018 07:42

novo nordisk... a big company, lets hope this is the first of many such collaborations

[ali47fish] 10/8/2018 13:30

this keeps rising and no clue why- stupid to be missing the boat? and no idea where this is going? any enlightenment would be welcome

[eastbourne1982] 16/1/2018 12:19

Some chunky buys going through recently, I reckon this could pop over 10p soon.

[ali47fish] 03/1/2018 07:22

ned puts in 50000- is it time to add

[melodrama] 18/12/2017 09:58

Bought some Friday and today, Dirs keen

[eastbourne1982] 16/6/2017 11:13

Someone / people seem to be loading up here, insider trading ?

[luckymouse] 14/6/2017 23:07

whats going on here - looks like a concert party buying in

free stock charts from uk.advfn.com

[letmepass] 14/6/2017 16:22

Back to 40 highs

[hutch_pod] 02/6/2017 18:24

As to why Richard Griffiths picked up c 54m ( from Aviva I guess) , and Lombard bought an extra 5m? Not sure, but it certainly woke things up, alongside the directors' buy.

[dynoport] 02/6/2017 16:22

lots happening today any info as to why?

[hutch_pod] 09/1/2017 07:11

Well, the new CEO seems impressive.

[dynoport] 20/9/2016 07:10

Founder leaving cannot be good :(

[gnnmartin] 26/5/2016 11:48

timbo, a good point. There was not a resolution on directors' remuneration. I guess it is not required for AIM companies.

[hutch_pod] 26/5/2016 09:46

Hi gnnmartin, thank you for the helpful writeup.

Interesting to see the Searchbolt acquisition as defensive, and especially if the focus is now on the platform and partnering deals.

Cheers
HP

[timbo003] 25/5/2016 21:51

Nigel, could it be anything to do with Malcolm's ridiculously large remuneration? He has to be the best paid CEO (by a mile) for any sub £100m life sciences company on AIM.

Was it a similar voting pattern for the resolutions concerning the remuneration report and remuneration policy?

[gnnmartin] 25/5/2016 20:28

I went to the AGM today. Nothing new to report. I went to ask for more information about the proposal to buy back Searchbolt that TW was so scathing about.

Iain Ross, non-exec chairman appointed January this year, told me that it was his guidance that triggered the action. Searchbolt had not been commercially successful and had some creditors that had potential spoiling power should ETX be successful in signing up a major pharmaceutical partner. Iain thought the possibility a patent troll like action from 3rd parties would be sufficiently off-putting to a major pharma, and it was worth (effectively) buying out the creditors.

I accept the explanation, though I don't know enough about the industry to make any informed judgement. I assume the concern is a consequence of the change of focus mentioned in the annual report: "Since originally identifying our first lead development compounds, substantial investment has enabled us to accelerate the development and expand the Company’s discovery capabilities and infrastructure. The platform is now the core focus for the business as it provides fast and accurate data enabling the identification of highly potent novel compounds which have the potential to be ‘game changers’ in established multiple, billion dollar markets.

One oddity came out of the meeting, possibly of no significance. The 4th motion was to re-elect Malcolm Young as director, and 3 proxy voters holding 47.3m votes between them abstained. I asked if there was any background to this, but was told no. Usually a deliberate abstention (as opposed to simply not bothering to vote) expresses some mild dissatisfaction or concern. With that number of votes being cast, one of the 3 abstainers was either Woodford or Aviva. Malcolm seems pretty central to the company strategy.

[postmanpat11] 20/5/2016 13:06

Cheers gooner108, bit of a punt on this one but could be big optionality

[geoff80] 11/5/2016 18:50

Tom W.[Shareprophets] has a low opinion of this share. Worth checking.

[hutch_pod] 22/3/2016 23:11

Agree. Looks like decent potential.

[jesusm] 22/3/2016 22:14

Thanks for the link ProactiveST. Good credible interview, very confident CEO with exciting propects for the future of the company.